Ch Hatz

Summary

Affiliation: University of Basel
Country: Switzerland

Publications

  1. doi request reprint Rabies: relevance, prevention, and management in travel medicine
    Christoph F R Hatz
    Swiss Tropical and Public Health Institute, Basel, Switzerland
    Infect Dis Clin North Am 26:739-53. 2012
  2. doi request reprint A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
    Christoph Hatz
    Division of Communicable Diseases, Institute for Social and Preventive Medicine, University of Zurich, 8001 Zurich, Switzerland
    Vaccine 30:3470-7. 2012
  3. pmc Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent
    R H Behrens
    Hospital for Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 5:7. 2006
  4. pmc The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 9:266. 2010
  5. pmc Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety
    Sarabel G Frey
    Division of Neuropaediatrics and Developmental Medicine, University Children s Hospital Basel, Switzerland
    Malar J 9:291. 2010
  6. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
  7. pmc Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition
    Erik Mossdorf
    St Francis Designated District Hospital, Ifakara, United Republic of Tanzania
    BMC Infect Dis 11:98. 2011
  8. pmc Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years
    Christoph Hatz
    Medical Department Swiss Tropical and Public Health Institute, P O Box, CH 4002 Basel, Switzerland
    Clin Vaccine Immunol 18:885-7. 2011
  9. doi request reprint Real-life versus package insert: a post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal® in healthy travellers
    Christoph Hatz
    Medical Department, Swiss Tropical and Public Health Institute Basel, Switzerland
    Vaccine 29:5000-6. 2011
  10. ncbi request reprint [Japanese encephalitis: risk for endemic populations and for travellers]
    C Hatz
    Département médical, Institut tropical et de santé publique suisse, 4002 Bâle
    Rev Med Suisse 6:956-9. 2010

Collaborators

Detail Information

Publications25

  1. doi request reprint Rabies: relevance, prevention, and management in travel medicine
    Christoph F R Hatz
    Swiss Tropical and Public Health Institute, Basel, Switzerland
    Infect Dis Clin North Am 26:739-53. 2012
    ..Only 51 human rabies cases that have not been transmitted by animal bites are described...
  2. doi request reprint A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
    Christoph Hatz
    Division of Communicable Diseases, Institute for Social and Preventive Medicine, University of Zurich, 8001 Zurich, Switzerland
    Vaccine 30:3470-7. 2012
    ..This dose range study aimed to identify priming antigen and adjuvant doses resulting in optimal levels of antibody-mediated protection after primary and one-year booster immunizations...
  3. pmc Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent
    R H Behrens
    Hospital for Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
    Malar J 5:7. 2006
    ..The group recommended non-selective prescribing of chemoprophylaxis for visitors to India, Pakistan, Bangladesh and Sri Lanka should be dropped...
  4. pmc The incidence of malaria in travellers to South-East Asia: is local malaria transmission a useful risk indicator?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 9:266. 2010
    ..The study was designed to examine whether the strategy of using malaria transmission in a local population was an accurate estimate of the malaria threat faced by travellers and a correlate of malaria in returning travellers...
  5. pmc Artesunate-mefloquine combination therapy in acute Plasmodium falciparum malaria in young children: a field study regarding neurological and neuropsychiatric safety
    Sarabel G Frey
    Division of Neuropaediatrics and Developmental Medicine, University Children s Hospital Basel, Switzerland
    Malar J 9:291. 2010
    ..Safety data for neurological and neuropsychiatric side effects of mefloquine and artesunate combination therapy in African children are scarce, although WHO recommends this therapy in Africa...
  6. pmc The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis?
    Ron H Behrens
    Travel Clinic, Hospital for Tropical Diseases, Mortimer Market, London, WC1E 6JB, UK
    Malar J 6:114. 2007
    ..The risk of adverse events are high and the benefit of avoided benign vivax malaria is very low under current policy, which may be causing more harm than benefit...
  7. pmc Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition
    Erik Mossdorf
    St Francis Designated District Hospital, Ifakara, United Republic of Tanzania
    BMC Infect Dis 11:98. 2011
    ..Data on combination antiretroviral therapy (cART) in remote rural African regions is increasing...
  8. pmc Successful memory response following a booster dose with a virosome-formulated hepatitis a vaccine delayed up to 11 years
    Christoph Hatz
    Medical Department Swiss Tropical and Public Health Institute, P O Box, CH 4002 Basel, Switzerland
    Clin Vaccine Immunol 18:885-7. 2011
    ..Delaying the booster dose did not influence the immune memory response to Epaxal...
  9. doi request reprint Real-life versus package insert: a post-marketing study on adverse-event rates of the virosomal hepatitis A vaccine Epaxal® in healthy travellers
    Christoph Hatz
    Medical Department, Swiss Tropical and Public Health Institute Basel, Switzerland
    Vaccine 29:5000-6. 2011
    ..Women reported higher rates of AEs than men. The results highlight the need for detailing the methods how vaccine tolerability was reported and assessed...
  10. ncbi request reprint [Japanese encephalitis: risk for endemic populations and for travellers]
    C Hatz
    Département médical, Institut tropical et de santé publique suisse, 4002 Bâle
    Rev Med Suisse 6:956-9. 2010
    ..A new vaccine against Japanese encephalitis will soon be registered in Switzerland. This paper contributes to the scarce data available for decision making whether or not to recommend the vaccination to tourists and expatriates...
  11. doi request reprint Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland
    Christoph Hatz
    Medical Department, Swiss Tropical Institute, Basel, Switzerland
    J Travel Med 16:200-3. 2009
    ..The risk of infection is unknown. This study attempts at estimating a risk incidence for visitors from two European countries with the available data...
  12. ncbi request reprint Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in nonimmune populations: a safety, efficacy, and pharmacokinetic study
    Christoph Hatz
    Medical Department, Swiss Tropical Institute, Basel, Switzerland
    Am J Trop Med Hyg 78:241-7. 2008
    ..In conclusion, the six-dose regimen of artemether-lumefantrine was effective and well tolerated in the treatment of acute uncomplicated falciparum malaria in nonimmune patients...
  13. ncbi request reprint [Malaria protection for short-term travelers]
    C Hatz
    Schweizerisches Tropeninstitut, Postfach, 4002, Basel
    Internist (Berl) 47:810-2, 814-7. 2006
    ..These elements help to reduce the rate of severe malaria cases among travelers...
  14. ncbi request reprint [Viruses without boundaries--risk of rabies during travel]
    Ch Hatz
    Schweizerisches Tropeninstitut, Basel
    Ther Umsch 60:657-61. 2003
    ..Cases without previous vaccination receive active plus passive protection from cell culture vaccine at days 0, 3, 7, 14 and 30, and preferably human rabies immune globulins (20 IU/kg BW) on day 0, injected around the site of the bite...
  15. ncbi request reprint Clinical and serologic responses to human 'apathogenic' trypanosomes
    J Blum
    Swiss Tropical Institute, Department of Medical and Diagnostic Services, Basel
    Trans R Soc Trop Med Hyg 99:795-7. 2005
    ..We performed serologic tests because the patient was worried about HAT after receiving tsetse bites. The possibilities of an infection with human 'apathogenic' trypanosomes such as T. b. brucei, T. congolense or T. vivax are discussed...
  16. ncbi request reprint [Asylum seekers and refugees in general practice: problems and possible developments]
    C Blöchliger
    Schweizerisches Tropeninstitut, Basel
    Soz Praventivmed 43:18-28. 1998
    ..General practitioners specialized in health care for asylum seekers and refugees is an option for providing improved specific services (interpreters, institutional links, culturally adapted medical care)...
  17. ncbi request reprint Impact of migration on illness experience and help-seeking strategies of patients from Turkey and Bosnia in primary health care in Basel
    D Gilgen
    Swiss Tropical Institute, P O Box 4002, Basel, Switzerland
    Health Place 11:261-73. 2005
    ....
  18. ncbi request reprint Treatment of cutaneous leishmaniasis among travellers
    J Blum
    Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland
    J Antimicrob Chemother 53:158-66. 2004
    ..An overview of published treatment options and a treatment recommendation is given for each of the most important species. The level of evidence of the studies leading to these recommendations is given...
  19. ncbi request reprint [Asylum seekers and refugees in the medical polyclinic: a comparison between the Basel, Bern and Geneva polyclinics]
    C Blöchliger
    Schweizerisches Tropeninstitut, Basel
    Soz Praventivmed 43:29-38. 1998
    ..In addition, the relationship between specific problems of asylum seekers and refugees and more general issues of the interaction between physicians and patients are discussed in view of tasks in research and training...
  20. ncbi request reprint [Asylum seekers and refugees in the emergency department]
    C Blöchliger
    Schweizerisches Tropeninstitut, Basel
    Soz Praventivmed 43:39-48. 1998
    ..Asylum seekers should be introduced to the tasks and functions of the various sectors of the national health care system as early as possible. Registration with a GP in the community should be promoted...
  21. ncbi request reprint Pretravel advice neglects rabies risk for travelers to tropical countries
    E Krause
    Medical Department, Swiss Tropical Institute, Basel, Switzerland
    J Travel Med 6:163-7. 1999
    ..In Switzerland this has now been done...
  22. ncbi request reprint Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?
    M Weisser
    Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland
    Clin Microbiol Infect 13:751-3. 2007
    ....
  23. ncbi request reprint [Medical travel counseling and vaccinations]
    C Hatz
    Medizinische Abteilung, Schweizerisches Tropeninstitut, Basel
    Praxis (Bern 1994) 89:868-77. 2000
    ....
  24. ncbi request reprint Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years
    C Hatz
    Swiss Tropical Institute, Basel
    Trop Med Int Health 3:498-504. 1998
    ..The study contributes to the discussion on treatment strategies, particularly whether chloroquine may still fulfil its role as first-line drug in an area of high malaria transmission and very high levels of chloroquine resistance...
  25. ncbi request reprint [50-year-old patient returning from Hawaii with changed stool habits. Blastocystis hominis]
    T Estlinbaum
    Medizinische Universitätspoliklinik, Kantonsspital Basel
    Praxis (Bern 1994) 91:936-8. 2002